中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2011年
8期
570-573
,共4页
李林蔚%余茜颖%李晓燕%郭黎平%周云%陆士新
李林蔚%餘茜穎%李曉燕%郭黎平%週雲%陸士新
리림위%여천영%리효연%곽려평%주운%륙사신
食管肿瘤%人食管癌相关基因4%甲基化
食管腫瘤%人食管癌相關基因4%甲基化
식관종류%인식관암상관기인4%갑기화
Esophageal neoplasms%Human esophageal cancer-related gene 4%Methylation
目的 探讨人食管癌相关基因4(ECRG4)在食管癌中表达缺失的机制.方法 采用聚 合酶链反应-单链构象多态(PCR-SSCP)和DNA测序的方法检测80对配对食管鳞状细胞癌(ESCC)肿瘤组织和癌旁正常上皮中ECRG4的外显子突变;采用DNA亚硫酸氧盐修饰和序列特异性聚合酶链反应(ssPCR)检测EC9706细胞系ECRG4基因启动子CpG岛甲基化状态;采用逆转录聚合酶链反应(RT-PCR)检测去甲基化药物5-氮杂-2-脱氧胞苷或三氧化二砷(As2O3)处理后ECRG4 mRNA的重新表达.结果 80对ESCC配对标本中,ECRG4的4个外显子编码区均未发现突变.EC9706细胞系ECRG4基因核心启动子区16个CpG岛中,有11个呈高甲基化状态,ECRG4 mRNA不表达.EC9706细胞处理前ECRG4 mRNA不表达,去甲基化药物处理后,ECRG4 mRNA均重新表达.结论 甲基化表观遗传学机制是导致ECRG4基因在食管癌细胞系EC9706中表达缺失的一个机制.
目的 探討人食管癌相關基因4(ECRG4)在食管癌中錶達缺失的機製.方法 採用聚 閤酶鏈反應-單鏈構象多態(PCR-SSCP)和DNA測序的方法檢測80對配對食管鱗狀細胞癌(ESCC)腫瘤組織和癌徬正常上皮中ECRG4的外顯子突變;採用DNA亞硫痠氧鹽脩飾和序列特異性聚閤酶鏈反應(ssPCR)檢測EC9706細胞繫ECRG4基因啟動子CpG島甲基化狀態;採用逆轉錄聚閤酶鏈反應(RT-PCR)檢測去甲基化藥物5-氮雜-2-脫氧胞苷或三氧化二砷(As2O3)處理後ECRG4 mRNA的重新錶達.結果 80對ESCC配對標本中,ECRG4的4箇外顯子編碼區均未髮現突變.EC9706細胞繫ECRG4基因覈心啟動子區16箇CpG島中,有11箇呈高甲基化狀態,ECRG4 mRNA不錶達.EC9706細胞處理前ECRG4 mRNA不錶達,去甲基化藥物處理後,ECRG4 mRNA均重新錶達.結論 甲基化錶觀遺傳學機製是導緻ECRG4基因在食管癌細胞繫EC9706中錶達缺失的一箇機製.
목적 탐토인식관암상관기인4(ECRG4)재식관암중표체결실적궤제.방법 채용취 합매련반응-단련구상다태(PCR-SSCP)화DNA측서적방법검측80대배대식관린상세포암(ESCC)종류조직화암방정상상피중ECRG4적외현자돌변;채용DNA아류산양염수식화서렬특이성취합매련반응(ssPCR)검측EC9706세포계ECRG4기인계동자CpG도갑기화상태;채용역전록취합매련반응(RT-PCR)검측거갑기화약물5-담잡-2-탈양포감혹삼양화이신(As2O3)처리후ECRG4 mRNA적중신표체.결과 80대ESCC배대표본중,ECRG4적4개외현자편마구균미발현돌변.EC9706세포계ECRG4기인핵심계동자구16개CpG도중,유11개정고갑기화상태,ECRG4 mRNA불표체.EC9706세포처리전ECRG4 mRNA불표체,거갑기화약물처리후,ECRG4 mRNA균중신표체.결론 갑기화표관유전학궤제시도치ECRG4기인재식관암세포계EC9706중표체결실적일개궤제.
Objective To investigate the mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) expression in esophageal squamous cell carcinoma (ESCC.) Methods PCR-SSCP and DNA sequencing analysis were used to detect the mutation of ECRG4 exons in esophageal cancer and matched adjacent normal tissues of 80 patients. DNA bisulfite-modifying ssPCR sequencing assay was used to examine the methylation status of ECRG4 promoter in human esophageal squamous cell carcinoma EC9706 cells. The re-expression of ECRG4 mRNA was examined by RT-PCR in EC9706 cells, after treatment with either demethylation drug 5-aza-2'-deoxycytidine or arsenic trioxide. Results No mutation in the four ECRG4 exons was found in all the ESCC and matched normal adjacent tissues. RT-PCR showed that 11 of 16 CpG islands of ECRG4 promoter were hypermethylated, while ECRG4 mRNA expression level was undetectable in the EC9706 cells. The ECRG4 mRNA was re-expressed after treatment with either demethylation drug 5-aza-2'-deoxycytidine or arsenic trioxide. Conclusion The epigenetic mechanism of methylation is a reason of loss of ECRG4 gene expression in the ESCC cell line EC9706.